Procter & Gamble Hygiene and Health Care Limited reported a 34% year-on-year decline in net profit to ₹126 crore for Q1FY26, down from ₹192.06 crore in the corresponding period of FY25. According to the company's unaudited financial results approved by the Board of Directors on July 29, 2026, revenue from operations contracted 5% to ₹891.46 crore compared to ₹940.03 crore in Q1FY25. The company attributed the profit decline to commodity cost fluctuations driven by geopolitical uncertainties, with EBITDA margin compressing sharply to 19.1% from 28.4% in the previous year, reflecting significant operational pressure amid strategic investments in innovation and advertising.
Procter & Gamble Hygiene and Health Care Limited has announced a final dividend of ₹60 per equity share for the financial year ended March 31, 2026. According to the company's exchange filing dated May 28, 2026, the dividend will be paid to shareholders whose names appear in the Register of Members as of the record date of September 1, 2026. The dividend has been recommended from the company's profits for the financial year 2025-26, with payment scheduled on or before September 18, 2026.
The company has updated its 62nd Annual General Meeting schedule with the AGM scheduled for Tuesday, September 8, 2026. As reported by ET Now, the record date for AGM purposes and dividend payment is September 1, 2026. If approved at the AGM, the dividend shall be paid to eligible members by October 6, 2026. The company has issued letters dated May 28, 2026 and July 10, 2026 regarding these updates.
Procter & Gamble Hygiene and Health Care shares are currently trading at ₹8,094.10, which is 0.02% below the previous close of ₹8,095.90 per share. According to ET Now, during the trading session, the stock swung between ₹8,141.85 and ₹8,092 per share. The stock reached its 52-week high level on September 29, 2025 at ₹14,493.15 per share, while the 52-week low came in at ₹8,070.35 per share on August 26, 2026. The company is a constituent of the BSE 500 index with a market capitalisation of ₹26,274.04 crore.
The 21% surge in advertising and sales promotion expenses to ₹83.32 lakhs from ₹68.73 lakhs in Q1FY25 indicates continued investment in brand visibility despite softer sales, with Managing Director Kumar Venkatasubramanian attributing the PAT impact to commodity cost fluctuations. Total expenses rose 7.53% to ₹731.26 lakhs, outpacing the revenue decline and compressing margins significantly. The absence of segment-wise disclosure, as Health Care and Hygiene products are aggregated into a single reportable segment, limits granular analysis of which product lines drove the volume or price mix changes. Despite operational challenges, the company maintains its dividend commitment with the significant payout representing a 450% payout to shareholders who meet the eligibility criteria based on the record date.
